Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Montelukast
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Montelukast 10mg tablets
0303020G0AAABAB
|
Montelukast | Montelukast | Respiratory System | 760,530 |
|
Montelukast 5mg chewable tablets sugar free
0303020G0AAAAAA
|
Montelukast | Montelukast | Respiratory System | 110,331 |
|
Montelukast 4mg chewable tablets sugar free
0303020G0AAACAC
|
Montelukast | Montelukast | Respiratory System | 40,444 |
|
Montelukast 4mg granules sachets sugar free
0303020G0AAADAD
|
Montelukast | Montelukast | Respiratory System | 24,354 |
|
Singulair 10mg tablets
0303020G0BBABAB
|
Singulair | Montelukast | Respiratory System | 2,572 |
|
Singulair Paediatric 5mg chewable tablets
0303020G0BBAAAA
|
Singulair | Montelukast | Respiratory System | 327 |
|
Singulair Paediatric 4mg granules sachets
0303020G0BBADAD
|
Singulair | Montelukast | Respiratory System | 84 |
|
Singulair Paediatric 4mg chewable tablets
0303020G0BBACAC
|
Singulair | Montelukast | Respiratory System | 71 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.